KDIL is a contract manufacturer of sterile injectables in India, as well as certain assets of NBZ Pharma.
Akorn is a pharmaceutical company engaged in the development, manufacture and marketing of multisource and branded pharmaceuticals.
Akorn CEO Raj Rai said the company looks forward to working closely with the Promoters of KDIL to provide a smooth transition in the coming months.